Clinical studies recruiting near Bakersfield

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · AIS Cancer Center at San Joaquin Community Hospital · NRG Oncology · NCT05624996 A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · Unio Specialty Care - A Genesis Healthcare Partners Facility · SURGE Therapeutics · NCT05710848 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Adventist Health - Bakersfield · Agendia · NCT03053193 Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients
Phase 1/Phase 2 · RayTx Clinical Site · Ray Therapeutics, Inc. · NCT07439887 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · Michael G Oefelein Clinical Trials · UroGen Pharma Ltd. · NCT06774131 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Michael G Oefelein, MD Clinical Trials · CG Oncology, Inc. · NCT06567743 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · AIS Cancer Center at San Joaquin Community Hospital · NRG Oncology · NCT05174169 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Michael G Oefelein Clinical Trials ( Site 0138) · Merck Sharp & Dohme LLC · NCT06833073 A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102 A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t
Phase 2 · Research Site · AstraZeneca · NCT07525375 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Kern Research, Inc.- Site Number : 8400047 · Sanofi · NCT07290803 A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults a
Phase 3 · GSK Investigational Site · ViiV Healthcare · NCT07650916 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Michael Oefelein Clinical Trials · Protara Therapeutics · NCT05951179 A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NA · Michael G Oefelein Clinical Trials · Rivermark Medical · NCT06849258 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · AIS Cancer Center at San Joaquin Community Hospital · NRG Oncology · NCT06748222 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 109 · Adverum Biotechnologies, Inc. · NCT07482176 Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · Kern Research Inc. · Sun Pharmaceutical Industries, Inc. · NCT07133308 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Phase 1/Phase 2 · Michael G Oefelein Clinical Trials ( Site 0053) · Merck Sharp & Dohme LLC · NCT06637423 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · California Retina Consultants (Bakersfield) · Kodiak Sciences Inc · NCT06990399 Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown O
Phase 3 · Kern Allergy and Medical Research- Site Number : 8400016 · Sanofi · NCT05263206 Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degen
Phase 2 · Adverum site 109 · Adverum Biotechnologies, Inc. · NCT07630649 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site · Merck Sharp & Dohme LLC · NCT03486873 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · California Retina Consultants · ONL Therapeutics · NCT06659445 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · AIS Cancer Center at San Joaquin Community Hospital · National Cancer Institute (NCI) · NCT06058377 A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urt
Phase 3 · Kern Research, Inc. · Celldex Therapeutics · NCT07266402 A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Phase 1/Phase 2 · Michael G Oefelein Clinical Trials ( Site 0005) · Merck Sharp & Dohme LLC · NCT07222488 Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-Hi
Phase 2 · Research Site · AstraZeneca · NCT06932263 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Kern Allergy and Medical Research · Hoffmann-La Roche · NCT05878769 Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · Research Site · AstraZeneca · NCT06750289 Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Phase 1/Phase 2 · Comprehensive Blood and Cancer Center · Georgiamune Inc · NCT06425926

Look up another city

Look up another condition